Early aggressive lipid-lowering strategy with PCSK9 siRNA performs better than usual care in US patients with ASCVD

Michael Gibson at the ACC24
Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Register

We're glad to see you're enjoying PACE-CME…
but how about a more personalized experience?

Register for free